Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

2.9%

4 terminated/withdrawn out of 139 trials

Success Rate

92.0%

+5.5% vs industry average

Late-Stage Pipeline

13%

18 trials in Phase 3/4

Results Transparency

2%

1 of 46 completed trials have results

Key Signals

28 recruiting1 with results

Enrollment Performance

Analytics

N/A
48(47.1%)
Phase 2
26(25.5%)
Phase 4
15(14.7%)
Phase 1
7(6.9%)
Early Phase 1
3(2.9%)
Phase 3
3(2.9%)
102Total
N/A(48)
Phase 2(26)
Phase 4(15)
Phase 1(7)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (139)

Showing 20 of 139 trials
NCT07571551Phase 2Not Yet Recruiting

Perioperative Trial With IO/TKI for Multi-stage Clear Cell Renal Cell Carcinoma

Role: lead

NCT05903560Not ApplicableRecruiting

Radial Versus Femoral Access For Thrombectomy in Patients With Acute Basilar Artery Occlusion

Role: lead

NCT03115931Completed

The Effect of Preoperative Nutritional Assessment and Nutritional Support on Clinical Outcomes

Role: lead

NCT07297238Not ApplicableRecruiting

Effect of GLP-1 on Intestinal Barrier Function in SBS-IF Patients: A Preliminary Exploration.

Role: lead

NCT06097962Early Phase 1Recruiting

Safety and Efficacy of NK510 to Treat NSCLC

Role: collaborator

NCT06114940Phase 2Terminated

Perioperative TORIPALIMAB Plus LENVATINIB in Patients With Renal Cell Carcinoma Undergoing Nephrectomy (PLUTO)

Role: lead

NCT07237542Not ApplicableRecruiting

Effect of Remote Ischemic Preconditioning on Early Neurological Deterioration in Acute Perforating Artery Infarction

Role: lead

NCT06334783Phase 1Terminated

TIL for Patients With Advanced Solid Tumor

Role: collaborator

NCT07294859Recruiting

Contrast-enhanced Ultrasound and Super-resolution Imaging Predict Renal Function Outcome After Nephrectomy

Role: lead

NCT07062952Not ApplicableRecruiting

Kidney-protective Intervention With Salt Substitute After Kidney Tumor Surgery

Role: lead

NCT04339166Not ApplicableCompleted

Embryo Selection by Noninvasive Preimplantation Genetic Test

Role: collaborator

NCT06818305Phase 2Terminated

Efficacy and Safety of Finerenone and Empagliflozin in Delaying Renal Function Progression After Radical Nephrectomy in High-Risk CKD Patients: A Multicenter RCT

Role: lead

NCT05917106Recruiting

Renal Cancer Monitoring Based on ctDNA Methylomics: A Prospective Cohort Study (MEMORY Study)

Role: lead

NCT06676527Recruiting

Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell Carcinoma

Role: lead

NCT04786743Not ApplicableRecruiting

Timing of Endoscopic Intervention for Acute Variceal Hemorrhage: an RCT

Role: lead

NCT06177522Phase 2Not Yet Recruiting

Adebrelimab Combined With Chemotherapy for Neoadjuvant Therapy in Resectable Pancreatic Cancer

Role: lead

NCT06139692Phase 4Recruiting

Comparison of Perioperative Conscious Sedation During Endovascular Thrombectomy in Acute Ischemic Stroke

Role: lead

NCT07230314Phase 2Not Yet Recruiting

Sequential Transarterial Chemoembolization (TACE), Stereotactic Body Radiation Therapy (SBRT), and Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma Treated With Donafenib

Role: lead

NCT06118840Not ApplicableRecruiting

IDEAL Study: Blinded RCT for the Impact of AI Model for Cerebral Aneurysms Detection on Patients' Diagnosis and Outcomes

Role: lead

NCT07186608Not ApplicableCompleted

Specific Dietary Fibers May Enhance Colonic Adaptation in Short Bowel Syndrome Through Microbial and Metabolic Mechanisms That Drive Functional Compensation.

Role: lead